ProfileGDS5822 / ILMN_2757445
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 87% 85% 84% 88% 87% 88% 87% 87% 84% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1318.787
GSM1276600PDAC Late Ablation Control 2261.785
GSM1276601PDAC Late Ablation Control 3295.484
GSM1276602PDAC Late Ablation 1385.588
GSM1276603PDAC Late Ablation 2356.787
GSM1276604PDAC Late Ablation 3443.488
GSM1303940PDAC Late Ablation_anti-CTLA4 1309.787
GSM1303941PDAC Late Ablation_anti-CTLA4 2415.387
GSM1303942PDAC Late Ablation_anti-CTLA4 3290.684